TY - JOUR
T1 - Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest sephardic ancestry
AU - Warshauer, Emily Mira
AU - Brown, Adam
AU - Fuentes, Ignacia
AU - Shortt, Jonathan
AU - Gignoux, Chris
AU - Montinaro, Francesco
AU - Metspalu, Mait
AU - Youssefian, Leila
AU - Vahidnezhad, Hassan
AU - Jacków, Joanna
AU - Christiano, Angela M.
AU - Uitto, Jouni
AU - Fajardo-Ramírez, Óscar R.
AU - Salas-Alanis, Julio C.
AU - McGrath, John A.
AU - Consuegra, Liliana
AU - Rivera, Carolina
AU - Maier, Paul A.
AU - Runfeldt, Goran
AU - Behar, Doron M.
AU - Skorecki, Karl
AU - Sprecher, Eli
AU - Palisson, Francis
AU - Norris, David A.
AU - Bruckner, Anna L.
AU - Kogut, Igor
AU - Bilousova, Ganna
AU - Roop, Dennis R.
N1 - Funding Information:
We thank all the patients and their families for helping us to carry out this study. This study was supported by the Avotaynu Foundation, Epidermolysis Bullosa Research Partnership, Epidermolysis Bullosa Medical Research Foundation, Cure EB, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institute of Health (NIH) (R01AR059947 and U01AR075932), the Department of Defense (DOD) (W81XWH-18-1-0706), Dystrophic Epidermolysis Bullosa Research Association (DEBRA) International, and the Gates Frontiers Fund. We also want to give special thanks to Stephen Berman, MD, the Founding Director of the Epidermolysis Bullosa Center of Excellence at Children's Hospital Colorado, who has cared for Hispanic RDEB patients in Colorado for over three decades and originally suggested to us that these patients may be of Converso ancestry.
Funding Information:
We thank all the patients and their families for helping us to carry out this study. This study was supported by the Avotaynu Foundation, Epidermolysis Bullosa Research Partnership, Epidermolysis Bullosa Medical Research Foundation, Cure EB, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institute of Health (NIH) (R01AR059947 and U01AR075932), the Department of Defense (DOD) (W81XWH‐18‐1‐0706), Dystrophic Epidermolysis Bullosa Research Association (DEBRA) International, and the Gates Frontiers Fund. We also want to give special thanks to Stephen Berman, MD, the Founding Director of the Epidermolysis Bullosa Center of Excellence at Children's Hospital Colorado, who has cared for Hispanic RDEB patients in Colorado for over three decades and originally suggested to us that these patients may be of Converso ancestry.
Funding Information:
Avotaynu Foundation; Cure EB; Dystrophic Epidermolysis Bullosa Research Assocation International; Epidermolysis Bullosa Medical Research Foundation; Epidermolysis Bullosa Research Partnership; Gates Frontiers Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Numbers: R01AR059947, U01AR075932; U.S. Department of Defense, Grant/Award Number: W81XWH‐18‐1‐0706 Funding information
Publisher Copyright:
© 2021 Wiley Periodicals LLC.
PY - 2021/11
Y1 - 2021/11
N2 - Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genodermatosis caused by mutations in the gene coding for type VII collagen (COL7A1). More than 800 different pathogenic mutations in COL7A1 have been described to date; however, the ancestral origins of many of these mutations have not been precisely identified. In this study, 32 RDEB patient samples from the Southwestern United States, Mexico, Chile, and Colombia carrying common mutations in the COL7A1 gene were investigated to determine the origins of these mutations and the extent to which shared ancestry contributes to disease prevalence. The results demonstrate both shared European and American origins of RDEB mutations in distinct populations in the Americas and suggest the influence of Sephardic ancestry in at least some RDEB mutations of European origins. Knowledge of ancestry and relatedness among RDEB patient populations will be crucial for the development of future clinical trials and the advancement of novel therapeutics.
AB - Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genodermatosis caused by mutations in the gene coding for type VII collagen (COL7A1). More than 800 different pathogenic mutations in COL7A1 have been described to date; however, the ancestral origins of many of these mutations have not been precisely identified. In this study, 32 RDEB patient samples from the Southwestern United States, Mexico, Chile, and Colombia carrying common mutations in the COL7A1 gene were investigated to determine the origins of these mutations and the extent to which shared ancestry contributes to disease prevalence. The results demonstrate both shared European and American origins of RDEB mutations in distinct populations in the Americas and suggest the influence of Sephardic ancestry in at least some RDEB mutations of European origins. Knowledge of ancestry and relatedness among RDEB patient populations will be crucial for the development of future clinical trials and the advancement of novel therapeutics.
KW - epidermolysis bullosa
KW - genetics
KW - genodermatoses
UR - http://www.scopus.com/inward/record.url?scp=85113408866&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.62456
DO - 10.1002/ajmg.a.62456
M3 - Article
AN - SCOPUS:85113408866
SN - 1552-4825
VL - 185
SP - 3390
EP - 3400
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 11
ER -